| 90834-3 |
Myelin Ab |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90834-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Myelin Ab Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 90835-0 |
Myelin associated glycoprotein Ab.IgM |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90835-0 |
|
IB |
|
|
Both |
|
|
|
0 |
MAG IgM CSF Ql IB |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; gG; Glycoprot; Glycoproteins; GP; Immune blot; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; MAG; MAGM; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90836-8 |
Neuronal nuclear type 3 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90836-8 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu3 Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Neuronal nuclear type III; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90837-6 |
Neuronal nuclear type 3 Ab |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90837-6 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu3 Ab Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Neuronal nuclear type III; Nuc; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 90838-4 |
Neuronal nuclear type 3 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90838-4 |
|
Line blot |
|
|
Both |
|
|
|
0 |
Hu3 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Hu; Hu3; III; Neuronal nuclear type III; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
| 90839-2 |
N-methyl-D-aspartate receptor subunit 1 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90839-2 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
NMDAR1 Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9084-5 |
Protein intake |
MRat |
^Patient |
12H |
Qn |
|
|
ACTIVE |
Protein intake 12 hour |
|
MIN |
DefinitionDescription |
|
|
g/12 hours |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9084-5 |
|
|
|
|
|
|
|
|
0 |
Protein intake 12h |
|
|
|
|
|
12 hours; 12HR; IO_INTAKE_SALTS+CALORIES; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative |
2.48 |
1.0i |
|
|
|
|
|
|
|
g/(12.h) |
|
|
|
0 |
| 90840-0 |
N-methyl-D-aspartate receptor subunit 1 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90840-0 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
NMDAR1 Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Dilution factor; Dilution Factor (Titer); Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Paraneoplastic syndrome; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 90841-8 |
Purkinje cell cytoplasmic type 1 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90841-8 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-1 Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Yo Ab |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90842-6 |
Purkinje cell cytoplasmic type 1 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90842-6 |
|
Line blot |
|
|
Both |
|
|
|
0 |
PCA-1 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; i; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Yo Ab |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
| 90843-4 |
Purkinje cell cytoplasmic type 2 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90843-4 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-2 Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90844-2 |
Purkinje cell cytoplasmic type Tr Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90844-2 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Neuro; Neurology; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90845-9 |
Purkinje cell cytoplasmic type Tr Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90845-9 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Limbic encephalopathy; Neuro; Neurology; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90846-7 |
Purkinje cell cytoplasmic type Tr Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90846-7 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 90847-5 |
Zinc finger protein of the cerebellum 4 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90847-5 |
|
Line blot |
|
|
Both |
|
|
|
0 |
Zic4 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Paraneoplastic neurological syndrome; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Small Cell Lung Cancer; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Zic4; Zn |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
| 90848-3 |
Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IA |
|
ACTIVE |
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90848-3 |
|
IA |
|
|
Both |
|
|
|
0 |
MAG/SGPG IgM Titr CSF IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; Immune globulin M; Immunoglobulin M; MAG; MAG/SGPG; MAGM; MAG-SGPG; MEIA; Neuro; Neurology; Point in time; Random; Serology; SGPG.IGM; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 90849-1 |
Cefpodoxime 4.0 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
90849-1 |
|
Method for Slow-growing mycobacteria |
|
|
Both |
|
|
|
0 |
Cefpodoxime 4 ug/mL Islt SlowMyco |
|
|
|
|
|
4 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefodox; Cefpod 4.0 ug/mL; Cefpodoxime proxetil; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Orelox; Podomexef; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; Vantin |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9085-2 |
Protein intake |
MRat |
^Patient |
24H |
Qn |
|
|
ACTIVE |
Protein intake 24 hour |
|
MIN |
DefinitionDescription |
|
|
g/24 hours |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9085-2 |
|
|
|
|
|
|
|
|
0 |
Protein intake 24h |
|
|
|
|
|
1 day; 24 hours; 24HR; IO_INTAKE_SALTS+CALORIES; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative |
2.48 |
1.0i |
|
|
|
|
|
|
|
g/(24.h) |
|
|
|
0 |
| 90850-9 |
cefTAZidime 1.0 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
90850-9 |
|
Method for Slow-growing mycobacteria |
|
|
Both |
|
|
|
0 |
cefTAZidime 1 ug/mL Islt SlowMyco |
|
|
|
|
|
1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Ceftaz 1.0 ug/mL; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; TB; Tuberculosis |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90851-7 |
GJB2 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
GJB2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
90851-7 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
GJB2 gene Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Connexin 26; Cx26; Deafness, autosomal dominant 3; Deafness, autosomal recessive 1; DFNA3; DFNA3A; DFNB1; DFNB1A; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gap junction beta-2 protein gene; gap junction protein, beta 2, 26kDa; Genetics; GJB2 full mut analysis; Heredity; Heritable; HID; high-throughput sequencing; HTS; Inherited; KID; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; NSRD1; Point in time; PPK; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90852-5 |
Fax number |
Tele |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Patient Fax number |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN.PATIENT |
|
90852-5 |
|
|
|
|
Observation |
|
|
|
0 |
Patient Fax # |
|
|
|
|
|
ADMIN; ADMIN.PATIENT; No; Nominal; Num; Point in time; Random; Telecommunication number; Telephone number |
2.66 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90853-3 |
Final score |
Score |
^Patient |
Pt |
Qn |
DUKE-AD |
|
ACTIVE |
Final score [DUKE-AD] |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright �© 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission. |
|
|
|
|
SURVEY.DUKE-AD |
|
90853-3 |
|
DUKE-AD |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Duke Anxiety Depression Scale; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey |
2.65 |
2.65 |
|
|
|
|
Copyright �© 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission. |
|
|
{score} |
|
|
|
0 |
| 90854-1 |
Duke Anxiety Depression Scale |
- |
^Patient |
Pt |
- |
DUKE-AD |
|
ACTIVE |
Duke Anxiety Depression Scale [DUKE-AD] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright �© 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission. |
|
|
|
|
PANEL.SURVEY.DUKE-AD |
|
90854-1 |
|
DUKE-AD |
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
Pan; Panel; Panl; Pnl; Point in time; Random; Survey |
2.65 |
2.65 |
|
Panel |
|
|
Copyright �© 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission. |
|
|
|
|
|
|
0 |
| 90855-8 |
Posterior inter-arch deviation |
Type |
Teeth and gum |
Pt |
Nom |
|
|
ACTIVE |
Posterior inter-arch deviation Teeth and gum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DENTAL |
|
90855-8 |
|
|
|
|
Observation |
|
|
|
0 |
Post inter-arch deviation Teeth+gum |
|
|
|
|
|
Dental; Dentistry; Nominal; Point in time; Post inter-arch deviation; Random; Teeth+gum; Typ |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90856-6 |
Crossbite teeth |
Num |
Teeth and gum |
Pt |
Qn |
|
|
ACTIVE |
Crossbite teeth [#] |
|
ADD |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
DENTAL |
|
90856-6 |
|
|
|
|
Observation |
|
|
|
0 |
Crossbite teeth |
|
|
|
|
|
Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum |
2.65 |
2.65 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
